DAIC

MARCH 6, 2024

Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly. Lantheus announced that the U.S.

Pediatrics 105

Pediatrics Ultrasound Heart Transplant Echocardiogram 105

Frontiers in Cardiovascular Medicine

JANUARY 28, 2025

RAA features were characterised by comparing prenatal ultrasound data with anatomical casting results after pregnancy termination or postnatal imaging and surgical intervention to analyse the prognosis and misdiagnoses of fetal RAA.ResultsOf the 157 fetal RAA cases, 50 (31.8%) cases were isolated RAA and 107 (68.2%) cases were nonisolated RAA.

Ultrasound 52

Ultrasound Aortic Outcomes Anatomy 52

Frontiers in Cardiovascular Medicine

FEBRUARY 23, 2025

Early diagnosis and prompt treatment of CHD contribute to enhanced neonatal outcomes and survival rates; however, there is a shortage of proficient examiners in remote regions. Most studies utilized deep learning models using either ultrasound or echocardiographic images.

Congenital Heart Disease 52

Congenital Heart Disease Heart Disease Ultrasound Congenital 52

DAIC

APRIL 3, 2024

Now, with Caption AI technology, clinicians using Vscan Air SL handheld ultrasound will have access to real-time, step-by-step guidance to capture diagnostic-quality images and automated ejection fraction estimation to help inform clinical decisions across cardiac settings. Of these, approximately 30 are AI-enabled ultrasound innovations.

Ultrasound 81

Ultrasound Innovation Technology Cardiovascular Disease 81

DAIC

APRIL 2, 2025

and European societal guidelines that intravascular imaging with either optical coherence tomography (OCT) or intravascular ultrasound (IVUS) should be routinely used during complex coronary stent procedures, s ays first authorGregg W. These results extend the strong recommendations from recent U.S.

Stent 40

Stent Stents Outcomes Coronary Angiogram 40

Circulation: Cardiovascular Interventions

JANUARY 24, 2024

BACKGROUND:Prior clinical trials have demonstrated the efficacy of ultrasound-facilitated catheter-directed thrombolysis (USCDT) for the treatment of acute intermediate-risk pulmonary embolism (PE) using reduced thrombolytic doses and shorter infusion durations. Circulation: Cardiovascular Interventions, Ahead of Print.

Embolism 75

Embolism Thrombolysis Ultrasound Pulmonary 75

DAIC

APRIL 25, 2024

Clinical outcomes in peripheral vascular disease have consistently been shown to benefit from accurate intravascular measurements, yet adoption has been limited by the additional procedure time and training required to interpret images" noted S. Intravascular ultrasound guidance for lower extremity arterial and venous interventions.

Ultrasound 111

Ultrasound Technology Outcomes 111

Frontiers in Cardiovascular Medicine

FEBRUARY 7, 2024

We sought to investigate the predictive value of B-lines measured by lung ultrasound (LUS) on the risk of weaning failure from mechanical ventilation (MV) and in-hospital outcomes. The primary outcome was early MV weaning failure, defined as re-intubation within 72 h. for the primary outcome. male) were enrolled.

Ultrasound 69

Ultrasound Heart Failure Hospital Outcomes 69

Frontiers in Cardiovascular Medicine

MARCH 27, 2025

At baseline visit, women will be randomized to undergo 2D/3D/strain vascular ultrasound (360 with imaging vs. 360 age- and RF-matched controls without imaging). Participants will attend a baseline visit and follow-up visits at 6 and 12-months.

Ultrasound 40

Ultrasound Plaque Blood Pressure Public Health 40

DAIC

JUNE 10, 2024

VeriSight Pro is designed for use with Philips’ premium ultrasound systems, EPIQ CVx, and EPIQ CVxi. “At Based on Philips’ innovative xMATRIX array 3D steerable beam ultrasound transducer technology, the VeriSight Pro 3D ICE captures high-quality 2D and 3D live images of the heart, including a 90-degree by 90-degree 3D field of view.

Ultrasound 105

Ultrasound Technology Hospital Tricuspid 105

DAIC

FEBRUARY 13, 2024

a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, announced today the commercial launch of its third-generation handheld point-of-care ultrasound (POCUS) system, Butterfly iQ3 , which received FDA clearance last month. The next-generation P4.3

Ultrasound 105

Ultrasound Technology Innovation Anatomy 105

Circulation

FEBRUARY 12, 2024

The 2 coprimary outcomes were target lesion revascularization and myocardial infarction. The secondary outcomes included ischemia-driven target lesion revascularization, target vessel myocardial infarction, death, cardiac death, target vessel revascularization, stent thrombosis, and major adverse cardiac events.

Ultrasound 67

Ultrasound Myocardial Infarction Thrombosis Stent 67

HCPLive

MAY 20, 2024

Dolinger reviews findings from his research presented at DDW about the use of intestinal ultrasound response for predicting endoscopic outcomes in children with UC.

Ultrasound 78

Ultrasound Research Outcomes 78

Journal of the American Heart Association

FEBRUARY 26, 2025

This study aims to investigate the relationship between sdLDLC level and PP in patients with stable coronary artery disease.MethodsWe conducted a retrospective analysis of 146 lesions in 86 patients by repeat intravascular ultrasound examinations from January 2020 to May 2023.

Ultrasound 56

Ultrasound Plaque Cholesterol Coronary Artery Disease 56

Cassling

JUNE 20, 2024

Though the public at large currently pictures consumer-focused tools like ChatGPT and the Dall-E image generator when they think of AI, a myriad of AI-based applications are being implemented in the background of healthcare systems around the country, improving patient outcomes and enhancing the workflows of providers everywhere.

Ultrasound 52

Ultrasound Echocardiogram Outcomes Blog 52

Open Heart

APRIL 18, 2022

Introduction Intravascular ultrasound (IVUS) improves clinical outcome in patients undergoing percutaneous coronary intervention (PCI) but dedicated prospective studies assessing the safety and efficacy of IVUS guidance during primary PCI are lacking.

Ultrasound 52

Ultrasound Myocardial Infarction Cardiovascular Imaging Plaque 52

Circulation: Cardiovascular Interventions

DECEMBER 27, 2024

Inverse probability weighting was used to assess the impact of IVUS on a composite outcome of repeat aortic intervention or death. IVUS was associated with a lower risk of the primary outcome at 30-days (hazard ratio, 0.80 [95% CI, 0.730.89];P<0.001) and 6-months (hazard ratio, 0.93 [95% CI, 0.870.99];P=0.022) for all-comers.

Ultrasound 40

Ultrasound Aortic Medicaid Medicare 40

DAIC

JUNE 4, 2024

This year’s program, “Global Echocardiography: Innovations in Diagnosis and Beyond,” is described as an educational experience gathering global experts and enthusiasts in echocardiography, hosted by the largest global organization for cardiovascular ultrasound imaging serving physicians, sonographers, nurses, and scientists.

Ultrasound 111

Ultrasound Education Research Technology 111

DAIC

JUNE 12, 2024

Consequently, Philips is well positioned to support CVI treatment by offering a robust portfolio of medical technology that includes both intravascular ultrasound and a differentiated venous stenting system.” Ultimately, the new device promises to enable excellent clinical outcomes and drive significant quality of life improvements.”

Stent 105

Stent Stents Anatomy Ultrasound 105

American College of Cardiology

APRIL 8, 2024

The goal of the IVUS-DCB trial was to evaluate intravascular ultrasound (IVUS)-guided drug-coated balloon angioplasty compared with angiography-guided drug-coated balloon angioplasty among patients with femoropopliteal artery disease.

Angioplasty 68

Angioplasty Ultrasound Outcomes Article 68

DAIC

NOVEMBER 8, 2024

Venita Chandra, director of vascular surgery, Stanford University School of Medicine, showed that DA followed by DCB achieved a significantly lower provisional stent rate with comparable safety and efficacy outcomes compared to standard predilatation prior to DCB, making it a viable alternative for treating long and highly calcified lesions.

Stent 52

Stent Stents Angioplasty Peripheral Arterial Disease 52

Open Heart

FEBRUARY 17, 2025

Intracoronary imaging, including intravascular ultrasound (IVUS) and optical coherence tomography (OCT), has been shown to improve outcomes for patients following PCI by reducing complications and the need for repeat procedures. Uptake remains highly variable, in part due to concerns over up-front costs.

Coronary Artery Disease 52

Coronary Artery Disease Ultrasound Hospital Outcomes 52

DAIC

JANUARY 15, 2024

The algorithm uses deep learning to analyse routine ultrasound scans of the heart ( echocardiograms ) to detect disease that often goes undetected during standard assessments. Over time, the build-up of these proteins causes the heart muscle to stiffen, eventually leading to heart failure, which can have dire outcomes if not found early.

Ultrasound 119

Ultrasound Coronary Artery Disease Innovation Heart Failure 119

Cassling

DECEMBER 14, 2023

We continue to be amazed by the imaging teams around the country who commit so much of themselves to improving patient outcomes.

Technology 98

Technology Innovation Ultrasound Article 98

Journal of the American Heart Association

FEBRUARY 14, 2025

BackgroundIschemic cardiomyopathy (ICM) is the end stage of ischemic heart disease, in which ventricular remodeling contributes to a fatal ventricular arrhythmia, worsens heart function and unfavorable outcomes, and is related to persistent chronic inflammation.

Ultrasound 45

Ultrasound Electrophysiology Cardiomyopathy Arrhythmia 45

DAIC

NOVEMBER 8, 2024

Procedures that previously required the use of two different devices can now be performed in a single procedure using a single device, simplifying workflows and procedures and potentially reducing the risk and improving outcomes for patients who might otherwise face multiple complex interventions. Patients will be followed for 12 months.

Innovation 52

Innovation Peripheral Arterial Disease Technology Ultrasound 52

DAIC

JANUARY 9, 2024

Improvements in outcomes following peripheral vascular intervention have lagged compared to other endovascular treatments, such as percutaneous coronary intervention. Ongoing collaboration among these specialties is paramount to improving outcomes for patients worldwide.” Tam, MD, MBA, FSIR.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Ultrasound Angioplasty Interventional Cardiology 105

DAIC

JANUARY 16, 2024

Developed at Children’s National Hospital and detailed in the latest edition of the Journal of the American Heart Association , the new AI system combines the power of novel ultrasound probes with portable electronic devices installed with algorithms capable of diagnosing RHD on echocardiogram. Beginning in March, Craig Sable, M.D.

Heart Disease 105

Heart Disease Ultrasound Technology Echocardiogram 105

Conquering CHD

JANUARY 17, 2025

Zane was diagnosed during a routine ultrasound at 20 weeks’ gestation and his mom, Kayla, was immediately referred to the Colorado Fetal Care Center (CFCC) at Childrens Hospital Colorado. The entire family has shown incredible resilience in the face of a challenging diagnosis, and I am personally honored to be a part of their story.

Heart Transplant 98

Heart Transplant Transplant Open-Heart Surgery Nursing 98

Frontiers in Cardiovascular Medicine

FEBRUARY 15, 2024

Objective The study aims to assess the ultrasonic features of fetal cardiac rhabdomyoma (CR), track the perinatal outcome and postnatal disease progression, investigate the clinical utility of ultrasound, MRI and tuberous sclerosis complex (TSC) gene analysis in CR evaluation, and offer evidence for determing of fetal CR prognosis.

Ultrasound 64

Ultrasound Risk Factors Outcomes Hospital 64

Cardiology Update

MAY 14, 2024

Intravascular imaging (IVI), such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), play a crucial role in assessing lesion characteristics and optimizing stent placement during percutaneous coronary intervention (PCI). Additionally, recent trials suggest similar outcomes between OCT-guided PCI and IVUS-guided PCI.

Outcomes 52

Outcomes Myocardial Infarction Ultrasound Article 52

DAIC

AUGUST 27, 2024

Food and Drug Administration (FDA) has granted 510(k) clearance for its first-of-a-kind, AI-powered AISAP CARDIO point-of-care ultrasound (POCUS) software platform. We know that structural heart disease and heart failure are the leading causes of hospitalization and morbidity in the U.S.

Ultrasound 98

Ultrasound Tricuspid Bicuspid/Mitral Aortic 98

DAIC

JUNE 13, 2024

Improving patient care and outcomes is what drives my commitment to helping find new solutions in the field. In addition to being locally trusted for improving patient outcomes through his medical practice at El Camino Health , Dr. St. He also played a key role in developing intravascular ultrasound, as well as the U.S.

Cardiothoracic 104

Cardiothoracic Interventional Cardiology Bicuspid/Mitral Innovation 104

Stroke: Vascular and Interventional Neurology

FEBRUARY 28, 2024

Recently, a novel, portable, noninvasive brain perfusion ultrasound device (SONAS) was developed as a diagnostic aid and demonstrated robust correlation with magnetic resonance imaging–based brain perfusion imaging. Safety end points included frequency, severity, and outcome of adverse events.RESULTSA total of 20 subjects were enrolled.

Ultrasound 40

Ultrasound Stroke Strokes Outcomes 40

DAIC

JUNE 11, 2024

The presenter will examine how you can harness the power of the CVIS and AI technologies to enhance structural heart workflow in the EP lab and ultrasound procedures. By leveraging AI, healthcare professionals can unlock new insights, automate repetitive tasks, and optimize throughput, ultimately leading to improved patient outcomes.

Webinar 119

Webinar Technology Best Practices Innovation 119

Circulation: Cardiovascular Interventions

NOVEMBER 28, 2023

BACKGROUND:There are limited data regarding the safety of deferral of percutaneous coronary intervention based on intravascular ultrasound (IVUS) findings. At 2 years, there was no difference in the cumulative incidence of vessel-oriented composite outcomes in deferred vessels between IVUS (n=375) and FFR (n=614) groups (3.8%

Outcomes 40

Outcomes Myocardial Infarction Ultrasound Stenosis 40

The American Journal of Cardiology

MARCH 22, 2024

Publication date: Available online 19 October 2023 Source: The American Journal of Cardiology Author(s): Irfan Shafi, Chadi Alraies

Ultrasound 40

Ultrasound Outcomes 40